Terms: = Brain cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Clinical Outcome
19 results:
1. [
Pruis IJ; Verburg FA; Balvers RK; Harteveld AA; Feelders RA; Vernooij MW; Smits M; Neggers SJCMM; Veldhuijzen van Zanten SEM
J Nucl Med; 2024 May; 65(5):688-692. PubMed ID: 38514085
[TBL] [Abstract] [Full Text] [Related]
2. Relevance of mutations in protein deubiquitinases genes and
Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
[TBL] [Abstract] [Full Text] [Related]
3. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
4. Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression.
Giannoudis A; Varešlija D; Sharma V; Zakaria R; Platt-Higgins A; Rudland PS; Jenkinson MD; Young LS; Palmieri C
ESMO Open; 2022 Dec; 7(6):100636. PubMed ID: 36423363
[TBL] [Abstract] [Full Text] [Related]
5. Exoscopic vs. microscopic transsphenoidal surgery for Cushing's disease: a retrospective single-center study on 388 patients.
Sumisławski P; Piffko A; Huckhagel T; Ryba A; Burkhardt T; Aberle J; Saeger W; Flitsch J; Rotermund R
Neurosurg Rev; 2022 Dec; 45(6):3675-3681. PubMed ID: 36136255
[TBL] [Abstract] [Full Text] [Related]
6. DZIP3 is a key factor to stratify IDH1 wild-type lower-grade gliomas.
Liang T; Zhou X; Li P; You G; Wang F; Wang P; Feng E
Aging (Albany NY); 2020 Nov; 12(24):24995-25004. PubMed ID: 33229627
[TBL] [Abstract] [Full Text] [Related]
7. CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma.
Liu F; Huang J; He F; Ma X; Fan F; Meng M; Zhuo Y; Zhang L
Sci Rep; 2020 Jul; 10(1):10768. PubMed ID: 32612110
[TBL] [Abstract] [Full Text] [Related]
8. Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG.
Knispel S; Stang A; Zimmer L; Lax H; Gutzmer R; Heinzerling L; Weishaupt C; Pföhler C; Gesierich A; Herbst R; Kaehler KC; Weide B; Berking C; Loquai C; Utikal J; Terheyden P; Kaatz M; Schlaak M; Kreuter A; Ulrich J; Mohr P; Dippel E; Livingstone E; Becker JC; Weichenthal M; Chorti E; Gronewold J; Schadendorf D; Ugurel S
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32371460
[TBL] [Abstract] [Full Text] [Related]
9. Influence of inferior petrosal sinus drainage symmetry on detection of adenomas in Cushing's syndrome.
Andereggen L; Gralla J; Schroth G; Mordasini P; Andres RH; Widmer HR; Luedi MM; Kellner F; Beck J; Mariani L; Ozdoba C; Christ E
J Neuroradiol; 2021 Feb; 48(1):10-15. PubMed ID: 31228539
[TBL] [Abstract] [Full Text] [Related]
10. Pineal Cyst-Related Aqueductal Stenosis as Cause of Intractable Headaches in Nonhydrocephalic Patients.
Pitskhelauri DI; Konovalov AN; Abramov IT; Danilov GV; Pronin IN; Alexandrova EV; Serova NK; Sanikidze AZ
World Neurosurg; 2019 Mar; 123():e147-e155. PubMed ID: 30468924
[TBL] [Abstract] [Full Text] [Related]
11. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer.
Machado-Rugolo J; Fabro AT; Ascheri D; Farhat C; Ab'Saber AM; de Sá VK; Nagai MA; Takagaki T; Terra R; Parra ER; Capelozzi VL
Hum Pathol; 2019 Jan; 83():177-191. PubMed ID: 30218756
[TBL] [Abstract] [Full Text] [Related]
12. High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patients.
Chakravarti N; Ivan D; Trinh VA; Glitza IC; Curry JL; Torres-Cabala C; Tetzlaff MT; Bassett RL; Prieto VG; Hwu WJ
Melanoma Res; 2017 Feb; 27(1):24-31. PubMed ID: 27768639
[TBL] [Abstract] [Full Text] [Related]
13. New therapeutic options for advanced non-resectable malignant melanoma.
Stadler S; Weina K; Gebhardt C; Utikal J
Adv Med Sci; 2015 Mar; 60(1):83-8. PubMed ID: 25596540
[TBL] [Abstract] [Full Text] [Related]
14. Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.
Di Giacomo AM; Ascierto PA; Queirolo P; Pilla L; Ridolfi R; Santinami M; Testori A; Simeone E; Guidoboni M; Maurichi A; Orgiano L; Spadola G; Del Vecchio M; Danielli R; Calabrò L; Annesi D; Giannarelli D; Maccalli C; Fonsatti E; Parmiani G; Maio M
Ann Oncol; 2015 Apr; 26(4):798-803. PubMed ID: 25538176
[TBL] [Abstract] [Full Text] [Related]
15. Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.
Metz MZ; Gutova M; Lacey SF; Abramyants Y; Vo T; Gilchrist M; Tirughana R; Ghoda LY; Barish ME; Brown CE; Najbauer J; Potter PM; Portnow J; Synold TW; Aboody KS
Stem Cells Transl Med; 2013 Dec; 2(12):983-92. PubMed ID: 24167321
[TBL] [Abstract] [Full Text] [Related]
16. Third ventricular chordoid glioma: clinicopathological study of two cases with evidence for a poor clinical outcome despite low grade histological features.
Kurian KM; Summers DM; Statham PF; Smith C; Bell JE; Ironside JW
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):354-61. PubMed ID: 16008819
[TBL] [Abstract] [Full Text] [Related]
17. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test.
Chen JC; Amar AP; Choi S; Singer P; Couldwell WT; Weiss MH
J Neurosurg; 2003 May; 98(5):967-73. PubMed ID: 12744355
[TBL] [Abstract] [Full Text] [Related]
18. Retinoic acid increases proliferation rate of GL-15 glioma cells, involving activation of STAT-3 transcription factor.
Paillaud E; Costa S; Fages C; Plassat JL; Rochette-Egly C; Monville C; Tardy M
J Neurosci Res; 2002 Mar; 67(5):670-9. PubMed ID: 11891779
[TBL] [Abstract] [Full Text] [Related]
19. Severe Lhermitte-Duclos disease with unique germline mutation of PTEN.
Sutphen R; Diamond TM; Minton SE; Peacocke M; Tsou HC; Root AW
Am J Med Genet; 1999 Feb; 82(4):290-3. PubMed ID: 10051160
[TBL] [Abstract] [Full Text] [Related]
